Why we built Carenostics

100,000 people are waiting for an organ transplant in the United States. Thirteen of them die every day, still waiting.

We lost a family member to the gaps in the transplant system. He fell through the cracks at early diagnosis, at proactive treatment, and ultimately at transplant. The infrastructure that should have connected the dots across his care journey did not exist. By the time the system fully engaged, it was already too late.

Inspired to prevent other families from enduring what ours did, we co-founded Carenostics on a conviction: that the gaps in transplant are not clinical failures but systems failures. And systems can be fixed.

Kanishka Rao

Co-Founder & Chief Executive Officer

Bharat Rao

Co-Founder, President & Chief AI Officer

The principles

What we believe.

Healthcare was built for the crisis, not the journey.

Healthcare is built to treat the critically ill, not prevent critical illness. By the time the system engages, it's often too late.

Detection without action changes nothing.

Healthcare has gotten better at flagging patients who need care. It still hasn't built the machinery to act on what it finds.

The clinicians are not the problem.

Better outcomes don't come from better clinicians. They come from fixing the conditions excellent clinicians work in.

General tools do not work in specialized care.

Transplant teams have been handed software adapted from other service lines for decades. They only trust what was built for their discipline. That is experience, not resistance.

The commitment

Built for transplant.
Here to stay.

Built for transplant

Not a general AI company that landed in transplant. Coordinators, administrators, surgeons, and transplant-specific workflows are why the product exists.

End-to-end across the workflow

Referral, evaluation, listing, waitlist maintenance, and post-transplant monitoring. One assistant across the full patient journey.

Here to stay, and still building

Implementation is the start, not the finish. Carenostics keeps building alongside transplant centers, shipping new capabilities as their needs evolve.

The team

Leadership.

The backers

Investors and Advisors.

The chairman of Humana's board, the former CEO of Siemens Health Services, and the first-ever Chief Technology Officer of the United States have looked at what Carenostics is building and decided it is worth backing.

Kurt Hilzinger

Chairman, Humana

John Glaser, PhD

Former CEO, Siemens Health Services

Aneesh Chopra

Former Chief Technology Officer, United States

Srinivas Devadas, PhD

Professor and Former Chair of Computer Science, MIT

Kash Patel, MS

Former CIO, Hackensack Meridian Health

Rayid Ghani, MS

Distinguished Career Professor of CS, Carnegie Mellon

Erman Ayday, PhD

Professor of Machine Learning Privacy, Case Western Reserve

Latif Peracha

General Partner, M13

Avi Goldberg

Partner, GreatPoint Ventures

Matthew Holt, MS

Founder, Health 2.0 (sold to HIMSS)

Jake Prigoff, MD

Partner, Gaingels

Daniel Belzer, JD

Partner, Sheppard Mullin

The press